Preventive treatment for latent tuberculosis from Indian perspective
The persistent morbidity and mortality associated with tuberculosis (TB), despite our continued efforts, has been long recognized, and the rise in the incidence of drug-resistant TB adds to the preexisting concern. The bulk of the TB burden is confined to low-income countries, and rigorous efforts a...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| Series: | Lung India |
| Subjects: | |
| Online Access: | http://www.lungindia.com/article.asp?issn=0970-2113;year=2024;volume=41;issue=1;spage=47;epage=54;aulast=Hashim |
| _version_ | 1797231725905969152 |
|---|---|
| author | Zia Hashim Richa Tyagi Gajendra Vikram Singh Alok Nath Surya Kant |
| author_facet | Zia Hashim Richa Tyagi Gajendra Vikram Singh Alok Nath Surya Kant |
| author_sort | Zia Hashim |
| collection | DOAJ |
| description | The persistent morbidity and mortality associated with tuberculosis (TB), despite our continued efforts, has been long recognized, and the rise in the incidence of drug-resistant TB adds to the preexisting concern. The bulk of the TB burden is confined to low-income countries, and rigorous efforts are made to detect, notify, and systematically treat TB. Efforts have been infused with renewed vigor and determination by the World Health Organization (WHO) to eliminate tuberculosis in the near future. Different health agencies worldwide are harvesting all possible strategies apart from consolidating ongoing practices, including prevention of the development of active disease by treating latent TB infection (LTBI). The guidelines for the same were already provided by the WHO and were then adapted in the Indian guidelines for the treatment of LTBI in 2021. While the long-term impact of TBI treatment is awaited, in this article, we aim to discuss the implications in the Indian context. |
| first_indexed | 2024-03-07T22:59:58Z |
| format | Article |
| id | doaj.art-2df5790bb44646b3a16fa5f62d17db7a |
| institution | Directory Open Access Journal |
| issn | 0970-2113 0974-598X |
| language | English |
| last_indexed | 2024-04-24T15:48:57Z |
| publishDate | 2024-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Lung India |
| spelling | doaj.art-2df5790bb44646b3a16fa5f62d17db7a2024-04-01T12:58:47ZengWolters Kluwer Medknow PublicationsLung India0970-21130974-598X2024-01-01411475410.4103/lungindia.lungindia_336_23Preventive treatment for latent tuberculosis from Indian perspectiveZia HashimRicha TyagiGajendra Vikram SinghAlok NathSurya KantThe persistent morbidity and mortality associated with tuberculosis (TB), despite our continued efforts, has been long recognized, and the rise in the incidence of drug-resistant TB adds to the preexisting concern. The bulk of the TB burden is confined to low-income countries, and rigorous efforts are made to detect, notify, and systematically treat TB. Efforts have been infused with renewed vigor and determination by the World Health Organization (WHO) to eliminate tuberculosis in the near future. Different health agencies worldwide are harvesting all possible strategies apart from consolidating ongoing practices, including prevention of the development of active disease by treating latent TB infection (LTBI). The guidelines for the same were already provided by the WHO and were then adapted in the Indian guidelines for the treatment of LTBI in 2021. While the long-term impact of TBI treatment is awaited, in this article, we aim to discuss the implications in the Indian context.http://www.lungindia.com/article.asp?issn=0970-2113;year=2024;volume=41;issue=1;spage=47;epage=54;aulast=Hashimisoniazid preventive treatmentlatent tuberculosis infectiontb diagnosistb eliminationtb in low-income countriestuberculosis prevention |
| spellingShingle | Zia Hashim Richa Tyagi Gajendra Vikram Singh Alok Nath Surya Kant Preventive treatment for latent tuberculosis from Indian perspective Lung India isoniazid preventive treatment latent tuberculosis infection tb diagnosis tb elimination tb in low-income countries tuberculosis prevention |
| title | Preventive treatment for latent tuberculosis from Indian perspective |
| title_full | Preventive treatment for latent tuberculosis from Indian perspective |
| title_fullStr | Preventive treatment for latent tuberculosis from Indian perspective |
| title_full_unstemmed | Preventive treatment for latent tuberculosis from Indian perspective |
| title_short | Preventive treatment for latent tuberculosis from Indian perspective |
| title_sort | preventive treatment for latent tuberculosis from indian perspective |
| topic | isoniazid preventive treatment latent tuberculosis infection tb diagnosis tb elimination tb in low-income countries tuberculosis prevention |
| url | http://www.lungindia.com/article.asp?issn=0970-2113;year=2024;volume=41;issue=1;spage=47;epage=54;aulast=Hashim |
| work_keys_str_mv | AT ziahashim preventivetreatmentforlatenttuberculosisfromindianperspective AT richatyagi preventivetreatmentforlatenttuberculosisfromindianperspective AT gajendravikramsingh preventivetreatmentforlatenttuberculosisfromindianperspective AT aloknath preventivetreatmentforlatenttuberculosisfromindianperspective AT suryakant preventivetreatmentforlatenttuberculosisfromindianperspective |